ArticleCancer immunology, immunotherapy : CII2024

Chemokine CCL21 determines immunotherapy response in hepatocellular carcinoma by affecting neutrophil polarization.

Wenxin Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.